Roberto Moretto

3.4k citations
88 papers · 2.6k · 1 hit paper · h-index 24

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Inflammatory Biomarkers in Disease Prognosis
    • Colorectal Cancer Surgical Treatments
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Colorectal Cancer Treatments and Studies 64
    • Colorectal Cancer Surgical Treatments 9
    • Cancer Immunotherapy and Biomarkers 5
    • Inflammatory Biomarkers in Disease Prognosis 2
    • Hepatocellular Carcinoma Treatment and Prognosis 3

Roberto Moretto

86 papers receiving 2.5k citations

Roberto Moretto's Hit Papers

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 2022 · 213 citations
2130+1+2Years since publication50100150200

Peers

Roberto Moretto
Comparison fields: 5 of 77
  • Oncology 1.9k
  • Internal Medicine 132
  • Pathology and Forensic Medicine 126
  • Cancer Research 80
  • Hepatology 38
Replace Lothar Müller with:
Lothar Müller Germany
Grazyna Liebérman United States
J. F. Seitz France
Heung Moon Chang South Korea
Lina Tang China
Heinz Josef Lenz United States
Nikolaos Ziras Greece
Michael McCleod United States
Francesco Gelsomino Italy
Roberto Moretto relative to Lothar Müller Germany Lothar Müller's profile →
Citations per field
00.5×2×2.8×
Lothar Müller · 1×
Citations per year

Countries citing papers authored by Roberto Moretto

Since Specialization
Citations

This map shows the geographic impact of Roberto Moretto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Moretto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Moretto more than expected).

Fields of papers citing papers by Roberto Moretto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Moretto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Moretto. The network helps show where Roberto Moretto may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Moretto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Moretto Line = papers co-authored together Roberto Moretto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020281
2 2020261
3
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
Hit paper breakdown →
2022213
4 2015143
5 2015139
6 2017135
7 2017107
8 201894
9 201690
10 202066
11 201964
12 202261
13 201554
14 202150
15 201645
16 202437
17 201834
18 201931
19 202131
20 202329

About Roberto Moretto

Roberto Moretto is a scholar working on Oncology, Hepatology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 2.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (64 papers), Colorectal Cancer Surgical Treatments (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), MRI in cancer diagnosis (2 papers), Genetic factors in colorectal cancer (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (1.9k citations), Internal Medicine (132 citations), Pathology and Forensic Medicine (126 citations), Cancer Research (80 citations) and Hepatology (38 citations). Roberto Moretto has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Chiara Cremolini, Alfredo Falcone, Carlotta Antoniotti, Gianluca Masi, Fotios Loupakis, Lisa Salvatore, Marta Schirripa, Filippo Pietrantonio, Sara Lonardi and Daniele Rossini. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, ESMO Open and Clinical Colorectal Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact